Portfolio company QurieGen was named one of Europe's Top 17 Deeptech Startups to Watch.
QurieGen is transforming drug development with a faster, cost-effective approach to creating effective treatments using AI and single-cell multi-omics
QurieGen is transforming drug development with a faster, cost-effective approach to creating effective treatments using AI and single-cell multi-omics.